Where is BioVersys headquartered?

BioVersys is located in Basel, basel-city.

Who invested in BioVersys?

BioVersys has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for BioVersys?

BioVersys closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

bioversys.com

BioVersys

BioVersys is a Switzerland-based clinical-stage biotechnology company that develops small-molecule therapeutics for the treatment of nosocomial infections.

Business Model:

Revenue: $5M

Employees: 11-50

Geographic Data

Address: Hochbergerstrasse 60c

City: Basel

State: basel-city

Zip: CH-4057

Country: CH

Financial Info

Stage:

series c

Raised Last:

$25M

Raised Total:

$91M

Social

Twitter

Crunchbase

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

BioVersys is a Switzerland-based clinical-stage biotechnology company that develops small-molecule therapeutics for the treatment of nosocomial infections.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
5/2009	Pre Seed Round	1	$91.9k	Venture Kick Venture Kick Venture Kick Venture Kick
1/2023	Series C		$0	AMR Action Fund AMR Action Fund
4/2021	Debt Financing	1	$24M	European Investment Bank European Investment Bank European Investment Bank European Investment Bank
3/2011	Seed Round	3	$2.7M	GoBeyond BioValley Business Angels Club (BioBAC) EVA Basel EVA Basel GoBeyond BioValley Business Angels Club (BioBAC) EVA Basel EVA Basel
11/2017	Series A	1	$5.1M	Business Angels Switzerland (BAS) Business Angels Switzerland (BAS) Business Angels Switzerland (BAS) Business Angels Switzerland (BAS)
6/2022	Series C		$24.7M
4/2021	Debt		$23.8M	European Investment Bank
10/2019	Grant	1	$8.9M	CARB-X CARB-X CARB-X CARB-X
9/2008	Grant	1	$18.4k	Venture Kick Venture Kick Venture Kick Venture Kick
6/2013	Series A		-
2/2021	Grant		$3M	European and Developing Countries Trial Partnership (EDCTP)
1/2023	Series C		$9M	The AMR Action Fund
9/2020	Series B	1	$20.9M	Business Angels Switzerland (BAS) Business Angels Switzerland (BAS) Business Angels Switzerland (BAS) Business Angels Switzerland (BAS)
5/2008	Grant	1	$9.7k	Venture Kick Venture Kick
6/2021	Grant		$0	CARB-X CARB-X
5/2021	Grant		$15.3M	CARB-X
6/2022	Series C		$24.9M	The AMR Action Fund
6/2022	Series C		$24.7M
6/2021	Grant	1	$4.3M	CARB-X CARB-X
4/2021	Debt Financing	1	$24M	European Investment Bank European Investment Bank European Investment Bank European Investment Bank
9/2020	Series B	1	$20.9M	Business Angels Switzerland (BAS) Business Angels Switzerland (BAS) Business Angels Switzerland (BAS) Business Angels Switzerland (BAS)
10/2019	Grant	1	$8.9M	CARB-X CARB-X CARB-X CARB-X
11/2017	Series A	1	$5.1M	Business Angels Switzerland (BAS) Business Angels Switzerland (BAS) Business Angels Switzerland (BAS) Business Angels Switzerland (BAS)
6/2013	Series A		-
3/2011	Seed Round	3	$2.7M	GoBeyond BioValley Business Angels Club (BioBAC) EVA Basel EVA Basel GoBeyond BioValley Business Angels Club (BioBAC) EVA Basel EVA Basel
5/2009	Pre Seed Round	1	$91.9k	Venture Kick Venture Kick Venture Kick Venture Kick
9/2008	Grant	1	$18.4k	Venture Kick Venture Kick Venture Kick Venture Kick

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details